Investment
Participated in FORE Biotherapeutics' upsized $67.4M Series D-2 Extension financing.
Fore Biotherapeutics
JUL 7, 2026
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Fore Biotherapeutics
Powerlist 2026: Dong-Su Kim
Config Intelligence
Cloaked
South 8
Genspark
Hyperlume
WeaveGrid
Figure AI
Dyna Robotics
America's Top Venture Capital Firms of 2025
Powerlist 2025: Dong-Su Kim
Summit Nanotech
ACT-ion